Page last updated: 2024-11-08

chloramphenicol and Corneal Neovascularization

chloramphenicol has been researched along with Corneal Neovascularization in 2 studies

Amphenicol: Chloramphenicol and its derivatives.

Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Höllhumer, R1
Zairani Mz, A1
Watson, S1
Jin, J1
Ma, JX1
Guan, M1
Yao, K1

Other Studies

2 other studies available for chloramphenicol and Corneal Neovascularization

ArticleYear
Hemorrhagic Descemet Membrane Detachment Following Syphilitic Interstitial Keratitis.
    Cornea, 2016, Volume: 35, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chloramphenicol; Combined Modality Therapy; C

2016
Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops.
    Cornea, 2010, Volume: 29, Issue:9

    Topics: Administration, Topical; Animals; Antigens, CD34; Blotting, Western; Cautery; Chloramphenicol; Chond

2010